Michael J. Fox - Parkinson's Disease

The Michael J. Fox Foundation has published four calls on Parkinson's disease. Deadline: May 31, 2018.

Alpha-Synuclein Biology and Therapies

The goal is to pursue alpha-synuclein research in order to advance understanding of alpha-synuclein biology and accelerate therapeutic approaches.

Biological Pathways & Novel targets:
Available per project: 150 000 USD

Therapeutic development:
Available per project: 500 000 USD

Duration: 1-2 years

GBA Biology and Therapies

The goal is to pursue GBA research in order to advance understanding of GBA biology and accelerate therapeutic approaches.

Biological Pathways & Novel targets:
Available per project: 150 000 USD

Therapeutic development:
Available per project: 500 000 USD

Duration: 1-2 years

Biomarkers of Protein Handling / Autopaghy, Exposomes and Lipids

The goal is to advance biomarker assays in three highly relevant Parkinson's disease (PD) biology research areas (protein handling/ autopaghy pathways, exposomes of neuronal origin, lipids).

Funding: Commensurable with the study goals

Non-Pharmacological Interventions for Gait and Balance Disturbances

The goal is to test non-pharmacological interventions for the treatment of gait and balance disturbances in people with Parkinson’s disease (PD). They are particularly interested in proof-of-concept, validation and data-analysis projects on therapeutic benefit of assistive devices, novel technologies, rehabilitative therapy programs

Available per project: 500 000 USD
Duration: 1-2 years

Application process

Two-stage process
First deadline: May 31, 2018
Second deadline: August 20, 2018

The foundation has planned a webinar on their funding opportunities May  10, 2018.

Link to calls

Alpha-Synuclein Biology and Therapies

GBA Biology and Therapies

Biomarkers of Protein Handling / Autopaghy, Exposomes and Lipids

Non-Pharmacological Interventions for Gait and Balance Disturbances

Published Mar. 23, 2018 1:00 PM - Last modified May 24, 2018 3:15 PM